(Q50547059)

English

The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.

scientific article published in January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Parkinson's disease

1 reference

based on heuristic

inferred from title

Jean-Christophe Corvol

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Jean-Sébastien Hulot

16

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

14

object named as

Yves Agid

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

Marie Vidailhet

17

object named as

Marie Vidailhet

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

author name string

Cécilia Bonnet

2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Fanny Charbonnier-Beaupel

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Anne-Marie Bonnet

4

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Marie-Hélène Fiévet

5

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Agnès Bellanger

6

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Emmanuel Roze

7

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Gayané Meliksetyan

8

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Mouna Ben Djebara

9

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Andreas Hartmann

10

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Lucette Lacomblez

11

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Cédric Vrignaud

12

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Noël Zahr

13

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Jean Costentin

15

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

publication date

1 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Annals of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

69

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

111-118

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA.

1 reference

https://api.crossref.org/works/10.1002%2FANA.22155

21 January 2018

Medical management of levodopa-associated motor complications in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FANA.22155

21 January 2018

Levodopa-related wearing-off in Parkinson's disease: identification and management

1 reference

https://api.crossref.org/works/10.1002%2FANA.22155

21 January 2018

New, selective catechol-O-methyltransferase inhibitors as therapeutic agents in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FANA.22155

21 January 2018

Variations in catechol-O-methyltransferase activity in inbred strains of rats

1 reference

https://api.crossref.org/works/10.1002%2FANA.22155

21 January 2018

Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.

1 reference

https://api.crossref.org/works/10.1002%2FANA.22155

21 January 2018

Determination of catechol-O-methyltransferase activity in erythrocytes by high performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1002%2FANA.22155

21 January 2018

Association between catechol-O-methyltransferase gene polymorphisms and wearing-off and dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FANA.22155

21 January 2018

COMT genotype and effectiveness of entacapone in patients with fluctuating Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FANA.22155

21 January 2018

Clinical experience of tolcapone in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FANA.22155

21 January 2018

Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FANA.22155

21 January 2018

Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FANA.22155

21 January 2018

Identifiers

10.1002/ANA.22155

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21280081

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50547059&oldid=1251916447"